Potential Benefits for Cardiovascular and Liver Health Phase 2 data showed reductions in liver fat content on MRI, relevant to MASLD, but dedicated cardiovascular outcomes trials have not yet been completed and cardiovascular benefits remain unconfirmed
The consumer patches sold online use none of these technologies
Avoid stacking two peptides that act on the same receptor, and introduce only one new peptide per week to isolate side effects
In the placebo arm, just 0.7% of patients reported this side effect
More receptors means more weight loss but also more side effects
Why it Works Feel satisfied sooner, stay full longer Reduces "food noise" & cravings Steady, sustainable weight loss Best for You've never tried GLP-1s before You want steady, consistent progress Tirzepatide Plan Dual GIP + GLP-1 agonist Remedy members lose 50 lbs in their first 6 months Top responders lose nearly 76 lbs in 12 months Designed for less side effects Our strongest compounded option